NCT07708155

Brief Summary

This pilot study evaluated the feasibility and usefulness of generative artificial intelligence (AI) as a clinical decision-support tool for physicians working in a medical intensive care unit. Participating physicians were assigned by work period to either use a generative AI system in addition to usual clinical information resources or to use usual resources without generative AI. The assigned condition was then switched so that participants experienced both approaches. During the AI-assisted periods, physicians used de-identified clinical information and considered the AI-generated responses as reference information. All final clinical decisions remained the responsibility of the treating physicians. The study assessed acceptability, usability, satisfaction, perceived decision support, workload, confidence, and learning experience through repeated questionnaires.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
15

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Dec 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2025

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 31, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 31, 2026

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

July 12, 2026

Completed
4 days until next milestone

First Posted

Study publicly available on registry

July 16, 2026

Completed
Last Updated

July 21, 2026

Status Verified

July 1, 2026

Enrollment Period

6 months

First QC Date

July 12, 2026

Last Update Submit

July 19, 2026

Conditions

Keywords

ChatGPTGenerative Artificial IntelligenceLarge Language ModelClinical Decision SupportPhysician Decision-MakingMedical Intensive Care UnitCritical CareUsabilityCluster-Randomized Crossover StudyAcceptability

Outcome Measures

Primary Outcomes (5)

  • Daily Physician Satisfaction Score

    The score of 10 questionnaire items assessing physicians' satisfaction with their daily clinical work, modified from Shore and Franks (1986) and Suchman et al. (1993). Each item was rated on a 5-point Likert scale from -2 (strongly disagree) to +2 (strongly agree). Negatively worded items were reverse-scored. The mean score ranges from -2 to +2, with higher scores indicating greater satisfaction.

    At the end of each working day during the one-month medical intensive care unit rotation

  • Daily Clinical Decision-Making Score

    The score of 6 questionnaire items assessing satisfaction with the clinical decision-making process, perceived decision difficulty, clarity of the preferred treatment, availability of relevant information, and identification of factors affecting the decision. Items were modified from Gedney (1994) and Dolan (1999) and rated on a 5-point Likert scale from -2 (strongly disagree) to +2 (strongly agree). Negatively worded items were reverse-scored. The mean score ranges from -2 to +2, with higher scores indicating a more favorable decision-making experience.

    At the end of each working day during the one-month medical intensive care unit rotation

  • Perceived Quality Score for ChatGPT

    The score of 8 questionnaire items assessing the perceived information quality, system quality, and service quality of ChatGPT, modified from Pillong et al. (2025). Each item was rated on a 5-point Likert scale from -2 (strongly disagree) to +2 (strongly agree). The negatively worded response-time item was reverse-scored. The mean score ranges from -2 to +2, with higher scores indicating better perceived quality.

    At the end of the one-month medical intensive care unit rotation, after completion of both crossover periods

  • Generative AI Usability Score

    The score of 3 questionnaire items assessing ease of use, ease of learning, and clarity of interaction with Generative AI (ChatGPT), modified from Pillong et al. (2025). Each item was rated on a 5-point Likert scale from -2 (strongly disagree) to +2 (strongly agree). The mean score ranges from -2 to +2, with higher scores indicating greater usability.

    At the end of the one-month medical intensive care unit rotation, after completion of both crossover periods

  • Satisfaction Score for Generative AI Use

    The score of 6 questionnaire items assessing the perceived usefulness, productivity, effectiveness, overall satisfaction, appropriateness, and intention to reuse Generative AI (ChatGPT), modified from Pillong et al. (2025). Each item was rated on a 5-point Likert scale from -2 (strongly disagree) to +2 (strongly agree). The mean score ranges from -2 to +2, with higher scores indicating greater satisfaction.

    At the end of the one-month medical intensive care unit rotation, after completion of both crossover periods

Other Outcomes (8)

  • Confidence

    At the end of the one-month medical intensive care unit rotation, after completion of both crossover periods

  • Perceived Acquisition of New Knowledge or Clinical Insight

    At the end of the one-month medical intensive care unit rotation, after completion of both crossover periods

  • Application of Generative AI-Derived Knowledge to Other Clinical Situations

    At the end of the one-month medical intensive care unit rotation, after completion of both crossover periods

  • +5 more other outcomes

Study Arms (2)

ChatGPT-Assisted Condition First, Then Control Condition

EXPERIMENTAL

Physician clusters used ChatGPT-assisted clinical decision support during the first approximately two weeks of their one-month medical intensive care unit rotation. They then crossed over to the control condition and used usual clinical information resources without generative AI for the remainder of the rotation.

Other: Generative AI-Assisted Clinical Decision SupportOther: Usual Clinical Information Resources

Control Condition First, Then ChatGPT-Assisted Condition

EXPERIMENTAL

Physician clusters used usual clinical information resources without generative AI during the first approximately two weeks of their one-month medical intensive care unit rotation. They then crossed over to the ChatGPT-assisted clinical decision-support condition for the remainder of the rotation.

Other: Generative AI-Assisted Clinical Decision SupportOther: Usual Clinical Information Resources

Interventions

During the assigned period, physicians were encouraged to use ChatGPT (OpenAI) as a generative AI-based reference tool to support clinical information review and decision-making.

ChatGPT-Assisted Condition First, Then Control ConditionControl Condition First, Then ChatGPT-Assisted Condition

During the control period, physicians used usual clinical information resources, including discussions with other clinicians, multidisciplinary rounds, specialty consultations, textbooks, clinical practice guidelines, PubMed, and established clinical reference services. No generative AI tool was used for clinical decision support during this period.

ChatGPT-Assisted Condition First, Then Control ConditionControl Condition First, Then ChatGPT-Assisted Condition

Eligibility Criteria

Age19 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age 19 years or older.
  • Physicians, including residents, fellows, and attending physicians, working in the medical intensive care unit at Seoul National University Hospital.
  • Scheduled to work as a primary treating physician for at least 5 days during a planned observation period.
  • Able and willing to provide written informed consent.

You may not qualify if:

  • Did not provide written informed consent.
  • Withdrew consent from study participation.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Seoul National University Hospital

Seoul, Seoul, 03080, South Korea

Location

Study Officials

  • Minju Han, M.D.

    Seoul National University Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
CROSSOVER
Model Details: The unit of randomization was the physician cluster within each one-month medical intensive care unit rotation. At the beginning of each one-month medical intensive care unit rotation, participating physicians were divided into two clusters. The physician clusters were randomized to one of two intervention sequences: the ChatGPT-assisted condition followed by the control condition, or the control condition followed by the ChatGPT-assisted condition. Each period lasted approximately two weeks, after which the clusters crossed over to the alternate condition. Thus, all participating physicians experienced both study conditions during the same monthly rotation.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 12, 2026

First Posted

July 16, 2026

Study Start

December 1, 2025

Primary Completion

May 31, 2026

Study Completion

May 31, 2026

Last Updated

July 21, 2026

Record last verified: 2026-07

Data Sharing

IPD Sharing
Will not share

Individual participant data will not be shared because of the small sample size, the limited number of physicians working in the study setting, and the potential risk of re-identification even after removal of direct identifiers. External sharing of individual-level data was not included in the participant consent or institutional review board-approved data management plan.

Locations